Clarient can help provide clarity for cancer patients and their physicians. The firm is a specialized diagnostic services provider, offering a collection of advanced tests that detect and monitor the progression of various types of cancer. In addition to testing materials, Clarient provides pathology lab services and delivers the test results via its PATHSiTE Web portal. The company's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies that outsource all or most of their specialized testing functions. Founded in 1993, Clarient was acquired by NeoGenomics from GE Healthcare in late 2015.